[Cells contain CMV and SV40 viral DNA sequences]
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
This cell line stably expresses the constitutively activated form of MEK1 and can be used in MEK-MAPK pathway studies
This cell line stably expresses constitutively activated form of MEK1(MEKDD), and can be used in MEK-MAPK pathway studies.
This cell line was derived from metastatic tumor and can be used to study breast cancer metastasis.
Glu-Glu tagged phosphorylation site MEK1 mutant (MEKDD), verified at ATCC.
constitutively activated form of MEK1, expressed
EpH4 1424.2 was derived from BALB/c mouse xenografts initiated with EpH4 cells stably transfected with an expression vector containing Glu-Glu epitope-tagged phosphorylation site MEK1 mutant (MEKDD). Cells were rederived from a metastatic tumor to the lung after selection with 1 mg/mL G418 in complete medium.
This cell line stably expresses constitutively activated form of MEK1(MEKDD, Asp218/Asp222 MEK1 phosphorylation site mutant), and can be used in MEK-MAPK pathway studies. This cell line was derived from metastatic tumor and can be used to study breast cancer metastasis.
Activation of MEK1 is mediated through phosphorylation of Ser218 and Ser222 by members of the Raf family of kinases.
This line related to four other cell lines: B-MEKDD 116 cell line (ATCC CRL-3069), EpH4 1424 cell line (ATCC CRL-3071), EpH4 1424.1 cell line (ATCC CRL-3209), and EpH4-Ev cell line (ATCC CRL-3063).
Medium renewal: Every 2 to 3 days
Temperature: 37°C
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Pinkas J, et al. MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition. Cancer Res. 62(16): 4781-90. PubMed: 12183438
